106584 Federal Register / Vol. 89, No. 249 / Monday, December 30, 2024 / Notices 

1Based on the Government’s submissions in its 

RFAA dated April 16, 2024, the Agency finds that 

service of the OSC on Registrant was adequate. The 

included declaration from a DEA Diversion 

Investigator (DI) indicates that on February 26, 

2024, the DI left a copy of the OSC at Registrant’s 

registered address. RFAAX 2, at 2. On the same 

date, the DI emailed a copy of the OSC to 

Registrant’s registered email address and to 

Registrant’s attorney. Id. at 2; see also id., 

Attachment C. On February 27, 2024, the OSC was 

mailed to Registrant’s residential address, with 

delivery confirmed on March 2, 2024. Id. at 2; see 

also id., Attachments D–E. Finally, on February 28, 

2024, the DI left another copy of the OSC at 

Registrant’s residential address. Id. at 2–3. The 

Agency finds that Registrant was successfully 

served the OSC by email on February 26, 2024, as 

the emails to Registrant’s registered email address 

and to Registrant’s attorney were not returned as 

undeliverable. Mohammed S. Aljanaby, M.D., 82 FR 

34,552, 34,552 (2017) (finding that service by email 

satisfies due process where the email is not 

returned as undeliverable and other methods have 

been unsuccessful). The Agency finds that the DI’s 

efforts to serve Registrant by other means were 

‘‘‘reasonably calculated, under all the 

circumstances, to apprise [Registrant] of the 

pendency of the action.’’’ Jones v. Flowers, 547 U.S. 

220, 226 (2006) (quoting Mullane v. Central 

Hanover Bank & Trust Co., 339 U.S. 306, 314 

(1950)). Therefore, due process notice requirements 

have been satisfied. 

Register Liaison Officer has been 

authorized to sign and submit the 

document in electronic format for 

publication, as an official document of 

DEA. This administrative process in no 

way alters the legal effect of this 

document upon publication in the 

Federal Register. 

Heather Achbach, 

Federal Register Liaison Officer, Drug 

Enforcement Administration. 

[FR Doc. 2024–31318 Filed 12–27–24; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1475] 

Importer of Controlled Substances 

Application: Siegfried USA, LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Siegfried USA, LLC has 

applied to be registered as an importer 

of basic class(es) of controlled 

substance(s). Refer to Supplementary 

Information listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before January 29, 2025. Such 

persons may also file a written request 

for a hearing on the application on or 

before January 29, 2025. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. All 

requests for a hearing must be sent to: 

(1) Drug Enforcement Administration, 

Attn: Hearing Clerk/OALJ, 8701 

Morrissette Drive, Springfield, Virginia 

22152; and (2) Drug Enforcement 

Administration, Attn: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing should 

also be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on November 20, 2024, 

Siegfried USA, LLC, 33 Industrial Park 

Road, Pennsville, New Jersey 08070, 

applied to be registered as an importer 

of the following basic class(es) of 

controlled substance(s): 

Controlled substance Drug code Schedule 

Phenylacetone ......................................................................................................................................................... 8501 II 

Opium, Raw ............................................................................................................................................................. 9600 II 

Poppy Straw Concentrate ........................................................................................................................................ 9670 II 

The company plans to import the 

listed controlled substances to 

manufacture bulk Active 

Pharmaceuticals Ingredients for 

distribution to its customers. No other 

activities for these drug codes are 

authorized for this registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration approved or nonapproved finished dosage forms for 

commercial sale. 

Matthew Strait, 

Deputy Assistant Administrator. 

[FR Doc. 2024–31301 Filed 12–27–24; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Matthew Okeke, M.D.; Decision and 

Order 

On February 14, 2024, the Drug 

Enforcement Administration (DEA or 

Government) issued an Order to Show 

Cause (OSC) to Matthew Okeke, M.D., of 

Las Vegas, Nevada (Registrant). Request 

for Final Agency Action (RFAA), 

Exhibit (RFAAX) 1, at 1, 3. The OSC 

proposed the revocation of Registrant’s 

Certificate of Registration No. 

FO4173845, alleging that Registrant’s 

registration should be revoked because 

Registrant is ‘‘currently without 

authority to handle controlled 

substances in Nevada, the state in which 

[he is] registered with DEA.’’ Id. at 2 

(citing 21 U.S.C. 824(a)(3)). 

The OSC notified Registrant of his 

right to file a written request for hearing, 

and that if he failed to file such a 

request, he would be deemed to have 

waived his right to a hearing and be in 

default. Id. (citing 21 CFR1301.43). 

Here, Registrant did not request a 

hearing. RFAA, at 2.1 ‘‘A default, unless 

excused, shall be deemed to constitute 

a waiver of the registrant’s/applicant’s 

right to a hearing and an admission of 

the factual allegations of the [OSC].’’ 21 

CFR 1301.43(e). 

Further, ‘‘[i]n the event that a 

registrant . . . is deemed to be in 

default . . . DEA may then file a request 

for final agency action with the 

Administrator, along with a record to 

support its request. In such 

circumstances, the Administrator may 

enter a default final order pursuant to 

[21 CFR] § 1316.67.’’ Id. § 1301.43(f)(1). 

Here, the Government has requested 


ddrumheller on DSK120RN23PROD with NOTICES1